论文部分内容阅读
目的观察曲美他嗪联合黄芪注射液治疗病毒性心肌炎的疗效。方法对符合急性病毒性心肌炎诊断标准的108例患者随机分为观察组62例和对照组46例,对照组常规应用能量合剂,利巴伟林针,观察组在对照组的治疗基础上加用黄芪注射液20g+5%葡萄糖注射液250ml,静滴,1次/d,2周为一疗程,曲美他嗪片20mg口服,3次/d,2周为一疗程。结果观察组总有效率98.39%,对照组总有效率65.22%。二组相比较差异有统计学意义(P<0.01)。结论本组研究结果表明,在常规治疗病毒性心肌炎的基础上应用曲美他嗪和黄芪注射液,具有疗效高,且无毒副作用,安全可靠。
Objective To observe the efficacy of trimetazidine combined with Astragalus injection in the treatment of viral myocarditis. Methods A total of 108 patients who met the diagnostic criteria of acute viral myocarditis were randomly divided into observation group (n = 62) and control group (n = 46). The control group was given conventional treatment with energy mixture, ribavirin injection and observation group on the basis of the control group Astragalus injection 20g + 5% glucose injection 250ml, intravenous infusion, 1 / d, 2 weeks for a course of treatment, trimetazidine tablets 20mg orally, 3 times / d, 2 weeks for a course of treatment. Results The total effective rate was 98.39% in observation group and 65.22% in control group. The difference between the two groups was statistically significant (P <0.01). Conclusion The results of this study show that, in the conventional treatment of viral myocarditis based on the application of trimetazidine and Astragalus injection, with high efficacy and no toxic side effects, safe and reliable.